پایا واکسن
  • Home
  • Products
    • payavax-g79

      PayaVax G79

    • payavax-g7

      PayaVax G7

    • payavax-h9

      PayaVax H9

  • Researches
    • PayaVaccine Articles
    • PayaVaccine Books
    • Related Articles
    • Refrence Books
  • Events
  • About us
  • collaboration
  • Contact us
ENenglish/FApersian
Paya vaccine
ENFA
  • Home
  • Products
  • Researches
  • Events
  • PayaVaccine Articles
  • PayaVaccine Books
  • About us
  • Contact us
PayaVax H9

PayaVax H9

PayaVax H9 is a monovalent inactivated vaccine designed to induce immunity in poultry against avian influenza caused by the H9N2 subtype. This vaccine is produced using a locally isolated virus strain and is manufactured in compliance with international standards, including Good Manufacturing Practices (GMP). Key Features: Effective immunity Optimized formulation Long-lasting protection Produced according to global standards Approved by the Veterinary Organization

Usage

PayaVax H9 is used to induce immunity in poultry—including broilers, breeders, and layers—against avian influenza caused by the H9N2 subtype.

Dosage and Administration

  • Birds under 14 days old: 0.2 mL per bird, administered subcutaneously.

  • Birds 14 to 60 days old: 0.3 mL per bird, administered subcutaneously.

  • Birds over 60 days old: 0.5 mL per bird, administered subcutaneously or intramuscularly.

  • Breeders and layers: Vaccination should be performed 14–21 days before the onset of egg laying (0.5 mL per bird).

Instructions for Use

  • Remove the vaccine vial from the refrigerator and allow it to reach room temperature.

  • Carefully read the provided instructions.

  • Shake the vial several times thoroughly to ensure a uniform solution, then draw the vaccine into the syringe.

Main Components

  • Inactivated avian influenza virus H9N2, isolated from a local Iranian strain

  • 10⁸ EID₅₀ per dose

Sterile Injection Protocol

Always use sterile equipment for injection to avoid contamination during the vaccination process.

Injection Methods

  • Subcutaneous injection: Administer in the lower neck region. Insert the needle under the skin and direct it toward the neck.

  • Intramuscular injection: Administer into the pectoral muscles at a 45° angle to prevent accidental injection into the abdominal cavity.

Storage Conditions

  • Store at 2–8°C

  • Protect from light.

Packaging

  • 500 mL bottle containing 2,500 doses

product name
Head Office:Alborz, Karaj, Taleghani Crossroad, Golha Street, Sepas Building, Unit 23
Factory Office:Alborz, 10th kilometer of Karaj–Qazvin Highway, before Kordan, Barekat Pharmaceutical Town
company location

Useful Links

  • Iran Veterinary Organization
  • Iran knowledge base website
  • Ministry of Agriculture Jihad
  • Iran Veterinary Council
  • World Organisation for Animal Health (WOAH)
  • Food and Agriculture Organization (FAO)
  • Developing Countries Vaccine Manufacturers Network (DCVMN)
+98 26 3223 1380
+98 919 083 94 57
info@payavaccine.com
@payavaccine
Paya Vaccine Tavana
telegram
Payavaccine Whatsapp